EUVIMEDEUVIMED entdecken
Crossref

Altered brain morphometry and its association with cognitive decline and APOE gene in normal people at risk for Alzheimer's disease

Min Zhao, Jiaxin Yang, Hewei Cheng, Yong Fan, for Alzheimer's Disease Neuroimaging Initiative

Journal of Alzheimer’s Disease · 2025

DOI: 10.1177/13872877251384967 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2025. Verfasst von Min Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Biomedical Engineering, Chongqing University of Posts and Telecommunications, Chongqing, China. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Alzheimer Disease, Brain, Apolipoproteins E. Die Arbeit nennt 90 Literaturangaben. Gefördert von: Natural Science Foundation of Chongqing Municipality, Science and Technology Research Project of Chongqing Education Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alzheimer's disease (AD) is a progressive neurodegenerative disorder marked by cognitive decline and memory impairment. Identifying early markers of AD is critical for timely diagnosis and intervention.

Objective

This study aimed to characterize the neuropsychological and pathological features of cognitively unimpaired (CU) individuals who later progressed to mild cognitive impairment (MCI) or AD, referred to as At-Risk CU. The goal was to support accurate staging and inform early therapeutic strategies.

Methods

Participants were categorized into CU, At-Risk CU, MCI, and AD groups. Data analyses focused on neuroimaging scans, neuropsychological assessments, cerebrospinal fluid (CSF) biomarkers (including Aβ 1–40 /Aβ 1–42 and p-Tau/t-Tau), and APOE genotypes. Voxel-based morphometry (VBM) was employed to assess gray matter (GM) volume and white matter (WM) integrity. Statistical analyses were conducted to evaluate group differences and associations.

Results

VBM revealed progressive GM atrophy and WM disruptions across the continuum from CU to At-Risk CU, MCI, and AD, particularly in the hippocampus and adjacent regions. Neuropsychological assessments showed significant cognitive decline across stages, while dynamic changes in CSF biomarkers in At-Risk CU suggested compensatory mechanisms. The APOE ε4 allele was strongly associated with AD progression, whereas the ε2 allele demonstrated protective effects. GM volume was significantly correlated with ADAS11 and ADAS13 scores.

Conclusions

This study identifies At-Risk CU as a distinct and clinically meaningful stage in AD progression, marked by structural, cognitive, and biomarker alterations. Integrating neuropsychological assessments, neuroimaging, and CSF biomarkers may facilitate early detection and enable targeted interventions to improve outcomes for individuals at elevated risk of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionAlzheimer DiseaseBrainApolipoproteins EHumansMaleFemaleAgedNeuropsychological TestsMagnetic Resonance ImagingMiddle AgedAmyloid beta-PeptidesAged, 80 and overBiomarkerstau ProteinsDisease ProgressionGray Matter

Stichwörter der Autor:innen

APOE geneAlzheimer's diseaseat risk for Alzheimer's diseasebrain atrophycognitive declinedeposition of Aβ and tau proteinsdisrupted white matter integrity

Substanzen

Apolipoproteins EAmyloid beta-PeptidesBiomarkerstau ProteinsApoE protein, human

Autor:innen und Institutionen

  • Research Center of Biomedical Engineering, Chongqing University of Posts and Telecommunications, Chongqing, China.
  • Chongqing Engineering Laboratory of Digital Medical Equipment and Systems, Chongqing University of Posts and Telecommunications, Chongqing, China.
  • Chongqing Engineering Research Center of Medical Electronics & Information Technology, Chongqing University of Posts and Telecommunications, Chongqing, China.
  • Chongqing Key Laboratory of Big Data for Bio Intelligence, Chongqing University of Posts and Telecommunications, Chongqing, China.
  • Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Förderung

  • Natural Science Foundation of Chongqing Municipality
  • Science and Technology Research Project of Chongqing Education Commission

Zitieren

APA

Zhao, M., Yang, J., Cheng, H., Fan, Y., & for Alzheimer's Disease Neuroimaging Initiative (2025). Altered brain morphometry and its association with cognitive decline and APOE gene in normal people at risk for Alzheimer's disease. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877251384967

Vancouver

Zhao M, Yang J, Cheng H, Fan Y, for Alzheimer's Disease Neuroimaging Initiative. Altered brain morphometry and its association with cognitive decline and APOE gene in normal people at risk for Alzheimer's disease. Journal of Alzheimer’s Disease. 2025. doi:10.1177/13872877251384967

BibTeX
@article{Zhao2025,
  author = {Zhao, Min and Yang, Jiaxin and Cheng, Hewei and Fan, Yong and for Alzheimer's Disease Neuroimaging Initiative, for Alzheimer's Disease Neuroimaging Initiative},
  title = {Altered brain morphometry and its association with cognitive decline and APOE gene in normal people at risk for Alzheimer's disease},
  journal = {Journal of Alzheimer’s Disease},
  year = {2025},
  doi = {10.1177/13872877251384967}
}
Kostenlos starten →